Man Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Man Group’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-948,492	Closed	-$32.1M	–	2199
2021 Q2	$32.1M	Buy	+948,492	New	+$24.2M	0.11%	195

Man Group's CNST Position: Q3 2021 in Review

Man Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 948,492 shares — an estimated $32.1M sold.

Man Group first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $32.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Man Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Man Group sold 948,492 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $32.1M.
Man Group first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Man Group's Constellation Pharmaceuticals, Inc. position peaked at $32.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Man Group's 13F filing for Q3 2021, filed 15 Nov 2021.